Rosiglitazone Investigated for Neuropathic Pain

The diabetes drug rosiglitazone (Avandia) is now being explored as a pain medication. The drug was initially controversial with some experts wanting to banish it and others wanting very tight restrictions. In a study that will be published in Anesthesia and Analgesia, a team from Juntendo University School of Medicine in Tokyo, Japan, has some new findings.  READ MORE

Source: MedScape Medical News